LDL cholesterol target attainment in a representative German cohort of high- and very-high-CV risk patients with statin intolerance: a simulation study

被引：0
|
作者：
Katzmann, J. [1 ]
Stuerzebecher, P. E. [1 ]
Kruppert, S. [2 ]
Laufs, U. [1 ]
机构：
[1] Univ Hosp Leipzig AoR, Leipzig, Germany
[2] IQVIA, Frankfurt, Germany
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Simulation study on LDL cholesterol target attainment, ASCVD events, and treatment cost of bempedoic acid in a representative German cohort of high- and very-high-CV risk patients
    Katzmann, J.
    Becker, C.
    Bilitou, A.
    Laufs, U.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2369 - 2369
  • [2] LDL cholesterol target attainment in cardiovascular high- and very-high-risk patients with statin intolerance: a simulation study
    Julius L. Katzmann
    Paulina E. Stürzebecher
    Silvia Kruppert
    Ulrich Laufs
    Scientific Reports, 14
  • [3] LDL cholesterol target attainment in cardiovascular high- and very-high-risk patients with statin intolerance: a simulation study
    Katzmann, Julius L.
    Stuerzebecher, Paulina E.
    Kruppert, Silvia
    Laufs, Ulrich
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [4] Atorvastatin treatment and LDL cholesterol target attainment in patients at very high cardiovascular risk
    Laufs, Ulrich
    Karmann, Barbara
    Pittrow, David
    CLINICAL RESEARCH IN CARDIOLOGY, 2016, 105 (09) : 783 - 790
  • [5] Atorvastatin treatment and LDL cholesterol target attainment in patients at very high cardiovascular risk
    Ulrich Laufs
    Barbara Karmann
    David Pittrow
    Clinical Research in Cardiology, 2016, 105 : 783 - 790
  • [6] Treatment strategies and LDL cholesterol target attainment in patients with statin intolerance: Insights from the multicentre statin intolerance registry
    Stuerzebecher, Paulina E.
    Katzmann, Julius L.
    Gouni-Berthold, Ionna
    Mateev, Christina
    Frenzel, Ole
    Schatz, Ulrike
    Baessler, Andrea
    Koenig, Wolfgang
    Schirmer, Stephan H.
    Mueller-Kozarez, Irina
    Weingaertner, Oliver
    Kassner, Ursula
    Laufs, Ulrich
    AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2025, 21
  • [7] Simulation study on LDL cholesterol target attainment, treatment costs, and ASCVD events with bempedoic acid in patients at high and very-high cardiovascular risk
    Katzmann, Julius L.
    Becker, Christian
    Bilitou, Aikaterini
    Laufs, Ulrich
    PLOS ONE, 2022, 17 (10):
  • [8] The role of ezetimibe in LDL cholesterol goal attainment in very high risk patients
    Mikhailidis, Dimitri P.
    Lawson, Richard W.
    McCormick, Anna-Louise
    Sibbring, Gillian C.
    Tershakovec, Andrew M.
    Davies, Glenn M.
    Tunceli, Kaan
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (10) : 1961 - 1961
  • [9] STATIN UTILISATION AND LDL-CHOLESTEROL GOAL ATTAINMENT IN VERY HIGH CARDIOVASCULAR RISK PATIENTS: INSIGHTS FROM AN ITALIAN GENERAL PRACTICE POPULATION
    Gorcyca, K.
    Tomic, R.
    Paizis, G.
    Chin, J.
    Sanchez, R.
    Khan, I.
    CARDIOLOGY, 2015, 132 : 56 - 57
  • [10] The role of ezetimibe in LDL cholesterol goal attainment in very high risk patients: the rosuvastatin monotherapy looks to be insufficient
    Mark, Laszlo
    Paragh, Gyoergy
    Reiber, Istvan
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (10) : 1959 - 1960
12345